Who is the CEO of Huvitz?

According to the DART company overview, Huvitz's representative director is 김현수 (name as registered in Korean). The company was founded on 1999-04-27.

Where is Huvitz listed?

Huvitz trades on the Korea Exchange KOSDAQ market under the ticker 065510. Its fiscal year ends in December.

Does Huvitz pay a dividend?

Yes. For fiscal 2025, Huvitz paid a cash dividend of ₩250 per common share, a 2.7% yield as stated in its annual report. The prior year's dividend was ₩200.

Does Huvitz have any recent filing signals?

Signals detected automatically from DART filings and quarterly results: Revenue & profit growth (latest quarterly revenue and operating profit both up more than 10% year on year). These are factual flags, not investment advice.

Which companies are in the same industry as Huvitz?

Under the Korean Standard Industrial Classification recorded on DART, Huvitz is grouped with 27 other listed companies in medical devices. The most covered in Korean news over the past 30 days are Seers, Sky Labs and Medyssey.

Huvitz KRX:065510KOSDAQ

휴비츠 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h0

Articles, 7 days0

DART filings, 7 days0

Articles tracked10since Sep 11

In Q2 2026, Huvitz reported revenue of ₩32.5bn, up 11.7% year on year, and operating profit of ₩2.1bn. Huvitz (휴비츠) appeared in 0 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 20 with 1 article. The most common catalyst was earnings (1).

Filing signals Revenue & profit growth Screener

Huvitz quarterly results consolidated, KRW

Quarter	Revenue	YoY	Operating profit	Net income
Q2 2026	₩32.5bn	+11.7%	₩2.1bn margin 6.6%	₩1.0bn
Q1 2026	₩29.7bn	-0.7%	₩2.6bn margin 8.8%	₩3.9bn
Q4 2025 derived	₩27.5bn	-8.4%	−₩2.1bn margin −7.6%	−₩9.8bn
Q3 2025	₩31.5bn	+5.2%	₩2.5bn margin 8.0%	₩3.5bn
Q2 2025	₩29.1bn	-6.0%	₩1.9bn margin 6.4%	−₩1.4bn
Q1 2025	₩29.9bn	+11.1%	₩3.3bn margin 10.9%	₩2.7bn
Q4 2024 derived	₩30.0bn	+5.0%	₩743m margin 2.5%	–
Q3 2024	₩29.9bn	-0.5%	₩4.0bn margin 13.3%	–

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Huvitz top stories 2 weeks, by number of outlets

1
휴비츠, 상반기 매출 5.4%↑…오스비스 품고 치과사업 강화
1 outlets · 1 articlesFirst report Oct 20 11:50 메디파나뉴스Earnings

Latest Huvitz news Korean headlines

Oct 2011:50

Major휴비츠, 상반기 매출 5.4%↑…오스비스 품고 치과사업 강화
메디파나뉴스Earnings
Oct 813:29

휴비츠, 덴탈 사업 통합 속도…오스비스 합병으로 '시너지' 노린다
MTN
Oct 722:49

휴비츠, 보통주 32만6136주 소각 결정
비건뉴스
Oct 714:01
휴비츠, 28억 규모 자사주 소각 결정
뉴시스경제
3 more on this story · 2 outlets
- 휴비츠, 28억 규모 자사주 소각 결정이데일리증권 · Oct 7 16:51
- 휴비츠, 28억 규모 자사주 소각 결정이데일리 · Oct 7 16:51
- 휴비츠, 28억 규모 자사주 소각 결정이데일리 · Oct 7 16:53
Oct 714:01
휴비츠, 자기주식 32만6000주 소각 결정…“주주가치 제고 일환”
이데일리
2 more on this story · 2 outlets
- 휴비츠, 자기주식 32만6000주 소각 결정…“주주가치 제고 일환”이데일리 · Oct 7 14:01
- 휴비츠, 자기주식 32만6000주 소각 결정…"주주가치 제고 지속"MTN · Oct 7 16:42

Articles per day 2 weeks

120

Company profile

CEO: 김현수
Industry: Medical devices
Founded: 1999-04-27
Fiscal year-end: December
Head office: 경기도 안양시
Website: huvitz.com
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

Huvitz dividends annual report

Korea dividend rankings

Year	Per share	Yield	Payout
FY2025	₩250	2.7%	–
FY2024	₩200	2.4%	25.0%
FY2023	₩200	1.1%	22.1%

Same industry Medical devices

All in industry

Company	Latest quarter op. profit	Articles 30d
Seers	₩12.9bn	76
Sky Labs	–	71
Medyssey	–	47
InBody	₩17.7bn	29
Cosmo Robotics	−₩3.3bn	24
Finemedix	₩790m	23
Dynamic solution	−₩950m	20
Hironic	₩1.1bn	19

Compare Huvitz side by side with these companies

Huvitz DART filings

Oct 713:14

Other 주식소각결정
Other
Sep 2814:38

Other 기타경영사항(자율공시) (소규모합병 승인 이사회 결의(주주총회 갈음) 결과보고)
Other

Catalysts 2 weeks

Earnings1

Mentioned alongside 2 weeks

No co-mentioned companies yet.

Huvitz FAQ

Who is the CEO of Huvitz?: According to the DART company overview, Huvitz's representative director is 김현수 (name as registered in Korean). The company was founded on 1999-04-27.
Where is Huvitz listed?: Huvitz trades on the Korea Exchange KOSDAQ market under the ticker 065510. Its fiscal year ends in December.
What were Huvitz's latest quarterly results?: In Q2 2026, Huvitz reported revenue of ₩32.5bn, up 11.7% year on year, and operating profit of ₩2.1bn. Figures come from reports filed on DART.
Does Huvitz pay a dividend?: Yes. For fiscal 2025, Huvitz paid a cash dividend of ₩250 per common share, a 2.7% yield as stated in its annual report. The prior year's dividend was ₩200.
Does Huvitz have any recent filing signals?: Signals detected automatically from DART filings and quarterly results: Revenue & profit growth (latest quarterly revenue and operating profit both up more than 10% year on year). These are factual flags, not investment advice.
Which companies are in the same industry as Huvitz?: Under the Korean Standard Industrial Classification recorded on DART, Huvitz is grouped with 27 other listed companies in medical devices. The most covered in Korean news over the past 30 days are Seers, Sky Labs and Medyssey.